Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
http://www.legalenglish.com/
Dena Falken is an International lawyer and Seminar presenter for Legal-Ease International Inc. a Worldwide company training Foreign Lawyers in Legal English and a wide range of services.
Visit www.legalenglish.com
EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
Today LeapFrog® Enterprises, Inc. announced the availability of its updated LeapStart™ Learning System, offering key enhancements to the successful, interactive learning system. Providing the perfect balance of core school and life skills, the LeapStart Learning System gets kids excited about counting, learning to read, problem solving and more with fun, replayable activities. Engaging new content featuring popular children’s characters, the availability of LeapFrog’s acclaimed Learn to Read series and a newly designed adaptable stylus give children the tools they need to build tomorrow’s skills today.
To view the multimedia release go to:
https://www.multivu.com/players/English/8140752-leapfrog-leapstart-new-content/
According to recent findings from Campos Inc., food customization is one of this year’s top consumer trends. Now, more than ever, consumers find endless options when it comes to customizing food – whether they are eating in or dining out. Along with exploring different flavors and food pairings, the baking industry is rethinking how they package recipes to consumers. In fact, according to Mintel, 45% of consumers surveyed want multiple preparation options and recipes listed on the packaging to allow them to express their personality.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7519851-lucky-leaf-customizable-desserts/
The following statement is being issued by Branstetter, Stranch & Jennings, PLLC regarding In re Prograf Antitrust Litigation.
A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (“Astellas” or “Defendant”) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version of the immunosuppressant prescription drug Prograf® (known as tacrolimus). Plaintiffs allege that Defendant’s conduct caused some consumers and third party payors to pay too much for Prograf in certain states from September 3, 2008 to December 31, 2010 (also referred to as the “Class Damage Period”). This lawsuit does not claim that Prograf is unsafe or ineffective. Astellas denies any wrongdoing.
To view the multimedia release go to:
http://www.multivu.com/players/English/7933851-prograf-antitrust-class-action-settlement/
Miral and SeaWorld Entertainment, Inc. (NYSE:SEAS) (“SeaWorld”) today announced their partnership to develop SeaWorld Abu Dhabi, a first-of-its-kind marine life themed park on Yas Island. This next generation SeaWorld Abu Dhabi will also include the United Arab Emirates’ (“UAE”) first dedicated marine life research, rescue, rehabilitation and return center with world-class facilities and resources for the care and conservation of local marine life. SeaWorld Abu Dhabi will be the first new SeaWorld without orcas, and will integrate up-close animal experiences, mega attractions and a world class aquarium, bringing the latest technology in visitor engagement.
The partnership brings together Miral’s expertise in developing Yas Island’s portfolio of destinations with SeaWorld’s 50-plus years of theme park, veterinary medicine, marine science and zoological practice and experience.
To view the multimedia release go to:
http://www.multivu.com/players/uk/8002251-miral-announces-seaworld-yas-island/
Tanger Factory Outlet Centers, Inc. announced today that in honor of the 25th annual Tanger PINK Campaign it will again offer shoppers great savings in return for supporting the ongoing efforts to end breast cancer during the month of October.
Launching today at Tanger Outlets across the United States and Canada, the Tanger PINK Campaign offers shoppers using the Shop Pink Card the opportunity to receive additional savings on the best brand name and designer fashions while helping to unite in the fight against breast cancer.
To view the multimedia release go to:
https://www.multivu.com/players/English/8385651-tanger-outlets-tanger-pink-campaign-against-breast-cancer/
http://www.legalenglish.com/software/
Legal-Ease International Inc. is the World Leader in Legal English. It now has a remarkable Software that has every Legal form you need available in English and Spanish. Every Legal Form for every Legal situation.
Save time and money
www.legalenglish.com/software
Tektronix, Inc., a leading worldwide provider of measurement solutions, has again broken through the innovation barrier with the introduction of the new 5 Series MSO mixed signal oscilloscope. To better meet modern electronics design challenges, the 5 Series MSO redefines the midrange oscilloscope with a host of innovations including the industry’s first FlexChannel™ technology that allows 4, 6 or 8 analog channels and up to 64 digital channels, integrated protocol analysis and signal generator, a new 12-bit signal acquisition system, a massive high-definition capacitive touch display, and a highly intuitive Direct Access user interface ¾ delivering unprecedented flexibility and unmatched visibility into complex embedded systems.
To view the multimedia release go to:
https://www.multivu.com/players/English/7990951-tektronix-5-series-mso-mixed-signal-oscilloscope/
Brock Beauty, Inc.’s bestselling hair vitamin Hairfinity® has been helping women grow healthier hair for more than 10 years. This Mother’s Day, founder Tai Lawrence is giving the world an intimate look into the inspiration behind the product – her daughter Jasmine – in a two minute short film called “They Learn From You.”
In “They Learn From You,” Tai describes her hair journey and shares her experience raising her daughter. “I struggled with my hair growing up. All of the chemicals, products and heat styling really did a number on the health of my hair,” said Tai Lawrence Brock Beauty Founder and visionary behind Hairfinity. “Most women have a childhood experience that defines their relationship with their hair. I wanted my little girl to feel good about her healthy hair and not be concerned about whether it was long, short, curly, textured or straight. That’s why Hairfinity® was created.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7522951-brock-beauty-hairfinity-hair-supplement/
The Light of Life Foundation, ThyCa: Thyroid Cancer Survivors’ Association, Inc., and Eisai Inc. today announced the launch of Myths and Truths About Thyroid Cancer, an interactive, educational campaign designed to help dispel the myth that thyroid cancer is a “good cancer.” Because most thyroid cancers can be successfully treated, many are told if you are going to get cancer, thyroid cancer is the one to have, which has led to this misperception. However, whether successfully treated or not, the truth is all cancers can have a significant impact on a person’s life, beginning with the shock and distress of hearing the word “cancer” at diagnosis. In honor of Thyroid Cancer Awareness Month and the tens of thousands who receive a thyroid cancer diagnosis each year, Myths and Truths About Thyroid Cancer illustrates the life-changing realities of this disease.
“As a thyroid cancer survivor, I urge people to stop referring to thyroid cancer as the ‘good cancer,’ as I believe it downplays patients’ experiences,” said Joan Shey, founder of the Light of Life Foundation. “I hear time and time again from patients how difficult their diagnosis and treatment were and that their scars are more than skin deep. My hope is that this campaign can educate about the many types of thyroid cancer and change the thyroid cancer conversation.”
“Being part of a community of survivors is very important for people coping with thyroid cancer,” said Gary Bloom, thyroid cancer survivor and co-founder and executive director of ThyCa: Thyroid Cancer Survivors’ Association. “ThyCa takes this to heart, which is why we are proud to provide support and resources to the thyroid cancer community. We also know more needs to be done to elevate awareness of thyroid cancer and what patients need in terms of support for the rest of our lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7595951-eisai-thyroid-cancer-myths/
